0001595215-17-000001.txt : 20170721 0001595215-17-000001.hdr.sgml : 20170721 20170721154853 ACCESSION NUMBER: 0001595215-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 EFFECTIVENESS DATE: 20170721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspyrian Therapeutics, Inc. CENTRAL INDEX KEY: 0001595215 IRS NUMBER: 272624716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291296 FILM NUMBER: 17976561 BUSINESS ADDRESS: STREET 1: 10581 ROSELLE STREET, SUITE 115 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-925-5619 MAIL ADDRESS: STREET 1: 10581 ROSELLE STREET, SUITE 115 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001595215 Aspyrian Therapeutics, Inc. 11080 ROSELLE STREET SAN DIEGO CA CALIFORNIA 92121 858-925-5619 DELAWARE None None Corporation true Miguel Garcia-Guzman 11080 Roselle Street San Diego CA CALIFORNIA 92121 Executive Officer Director Merrill Biel 11080 Roselle Street San Diego CA CALIFORNIA 92121 Executive Officer Director Hiroshi Mikitani 11080 Roselle Street San Diego CA CALIFORNIA 92121 Director Hiroshi Mori 11080 Roselle Street San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2017-07-07 false true false 0 19000000 15079974 3920026 false 45 0 0 0 false Aspyrian Therapeutics, Inc. Miguel Garcia-Guzman Miguel Garcia-Guzman Chief Executive Officer 2017-07-21